Commentary on “Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systemati...

par Colevas, A. Dimitrios
Publié dans Oncologist (2017)

The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck

par Russell, Jeffery S., Colevas, A. Dimitrios
Publié 2012

Differentiated Thyroid Cancer: Focus on Emerging Treatments for Radioactive Iodine-Refractory Patients

par Gruber, Joshua J., Colevas, A. Dimitrios
Publié dans Oncologist (2015)

Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck

par Iberri, David J., Colevas, A. Dimitrios
Publié dans Oncologist (2015)

Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck

par Iberri, David J., Colevas, A. Dimitrios
Publié dans Oncologist (2016)

Assessing Care Value for Older Patients Receiving Radiotherapy With or Without Cisplatin or Cetuximab for Locoregionally Advanced Head and Neck Cancer

par Saraswathula, Anirudh, Chen, Michelle M., Colevas, A. Dimitrios, Divi, Vasu
Publié dans JAMA Otolaryngol Head Neck Surg (2019)

Metastatic cutaneous squamous cell carcinoma responsive to cemiplimab in a patient with multiple myeloma

par Marukian, Nareh Valerie, Lin, John Q., Colevas, A. Dimitrios, Coutre, Steven, Chang, Anne Lynn S.
Publié dans JAAD Case Rep (2020)

Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes

par Huang, Chao, Cintra, Murilo, Brennan, Kevin, Zhou, Mu, Colevas, A. Dimitrios, Fischbein, Nancy, Zhu, Shankuan, Gevaert, Olivier
Publié dans EBioMedicine (2019)

CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma

par Mukherjee, Pritam, Cintra, Murilo, Huang, Chao, Zhou, Mu, Zhu, Shankuan, Colevas, A. Dimitrios, Fischbein, Nancy, Gevaert, Olivier
Publié dans Radiol Imaging Cancer (2020)

Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy

par Freites-Martinez, Azael, Kwong, Bernice Y., Rieger, Kerri E., Coit, Daniel G., Colevas, A. Dimitrios, Lacouture, Mario E.
Publié dans JAMA Dermatol (2017)

Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck

par Trieu, Vanessa, Pinto, Harlan, Riess, Jonathan W., Lira, Ruth, Luciano, Richard, Coty, Jessie, Boothroyd, Derek, Colevas, A. Dimitrios
Publié dans Oncologist (2018)

Phase I Study of Continuous Weekly Dosing of Dimethylamino Benzoylphenylurea (BPU) in Patients with Solid Tumours

par Messersmith, Wells A., Rudek, Michelle A., Baker, Sharyn D., Zhao, Ming, Collins, Connie, Colevas, A. Dimitrios, Donehower, Ross C., Carducci, Michael A., Wolff, Antonio C.
Publié 2006

The Sentinel Margin: Intraoperative ex-vivo Specimen Mapping Using Relative Fluorescence Intensity

par van Keulen, Stan, Nishio, Naoki, Birkeland, Andrew, Fakurnejad, Shayan, Martin, Brock, Forouzanfar, Tim, Cunanan, Kristen, Colevas, A. Dimitrios, van den Berg, Nynke Sjoerdje, Rosenthal, Eben
Publié dans Clin Cancer Res (2019)

Fluorescence molecular imaging for identification of high-grade dysplasia in patients with head and neck cancer

par Fakurnejad, Shayan, van Keulen, Stan, Nishio, Naoki, Engelen, Myrthe, van den Berg, Nynke S., Lu, Guolan, Birkeland, Andrew, Baik, Fred, Colevas, A. Dimitrios, Rosenthal, Eben L., Martin, Brock A.
Publié dans Oral Oncol (2019)

A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as se...

par Gubens, Matthew A., Chuang, Jody C., Akerley, Wallace, Langer, Corey J., Clément-Duchêne, Christelle, San Pedro-Salcedo, Melanie, Colevas, A. Dimitrios, Dragnev, Konstantin, Socinski, Mark A., Wakelee, Heather A.
Publié dans J Thorac Dis (2018)

Validation that Metabolic Tumor Volume Predicts Outcome in Head and Neck Cancer

par Tang, Chad, Murphy, James D., Khong, Brian, La, Trang H., Kong, Christina, Fischbein, Nancy J., Colevas, A. Dimitrios, Iagaru, Andrei H., Graves, Edward E., Loo, Billy W., Le, Quynh-Thu
Publié 2012

Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumors

par Kunz, Pamela L., He, Aiwu R., Colevas, A. Dimitrios, Pishvaian, Michael J., Hwang, Jimmy J., Clemens, Pamela L., Messina, Marianne, Kaleta, Remigiusz, Abrahao, Fernanda, Sikic, Branimir I., Marshall, John L.
Publié 2012

A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Non-squamous Non-small Cell Lung Cancer

par Clément-Duchêne, Christelle, Krupitskaya, Yelena, Ganjoo, Kristen, Lavori, Philip, McMillan, Alex, Kumar, Atul, Zhao, Gary, Padda, Sukhmani, Zhou, Lisa, Pedro-Salcedo, Melanie San, Colevas, A. Dimitrios, Wakelee, Heather A.
Publié dans J Thorac Oncol (2010)

Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma

par Ally, Mina S., Ransohoff, Katherine, Sarin, Kavita, Atwood, Scott X., Rezaee, Melika, Bailey-Healy, Irene, Kim, Jynho, Beachy, Philip A., Chang, Anne Lynn S., Oro, Anthony, Tang, Jean Y., Colevas, A. Dimitrios
Publié dans JAMA Dermatol (2016)

Phase II Study of the Addition of Bevacizumab to Standard Chemoradiation for Loco-regionally Advanced Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group (RTOG) Trial 0615

par Lee, Nancy Y., Zhang, Ed, Pfister, David. G., Kim, John, Garden, Adam. S., Mechalakos, James, Hu, Kenneth, Le, Quynh T., Colevas, A. Dimitrios, Glisson, Bonnie S., Chan, Anthony T.C., Ang, K. Kian
Publié dans Lancet Oncol (2011)